Saturday, October 31, 2026

Iron Mountain Incorporated And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Iron Mountain Incorporated And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

2. Sun Communities

68.2% sales growth and 3.84% return on equity

Sun Communities, Inc. is a REIT that, as of September 30, 2020, owned, operated, or had an interest in a portfolio of 432 communities comprising nearly 146,000 developed sites in 32 states and Ontario, Canada.

Sun Communities's sales growth this year is expected to be 11.5% and 41% for next year.

Year-on-year quarterly revenue growth grew by 42.7%, now sitting on 1.51B for the twelve trailing months.

Sun Communities's sales growth is a negative 0% for the ongoing quarter and 68.2% for the next. The company's growth estimates for the ongoing quarter and the next is a negative 30% and 21.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.84%.

Volatility

Sun Communities's last day, last week, and last month's current volatility was 0.26%, 0.47%, and 0.67%, respectively.

Sun Communities's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.70% (day), 1.45% (last week), and 1.57% (last month), respectively.

Sun Communities's Stock Yearly Top and Bottom Value

Sun Communities's stock is valued at $166.29 at 14:22 EST, below its 52-week high of $167.24 and way higher than its 52-week low of $118.81.

Sun Communities's Moving Average

Sun Communities's value is above its 50-day moving average of $153.78 and way above its 200-day moving average of $147.56.

3. Iron Mountain Incorporated

14.9% sales growth and 25.15% return on equity

Iron Mountain Incorporated (NYSE: IRM), founded in 1951, is the global leader for storage and information management services.

Iron Mountain Incorporated's sales growth this year is anticipated to be 5.1% and 4.1% for next year.

Year-on-year quarterly revenue growth declined by 1.8%, now sitting on 4.15B for the twelve trailing months.

Iron Mountain Incorporated's sales growth for the next quarter is 14.9%. The company's growth estimates for the present quarter and the next is a negative 7.4% and 36.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 25.15%.

Volatility

Iron Mountain Incorporated's last day, last week, and last month's current volatility was 1.29%, 0.49%, and 0.73%, respectively.

Iron Mountain Incorporated's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.80% (day), 1.67% (last week), and 1.83% (last month), respectively.

Iron Mountain Incorporated's Stock Yearly Top and Bottom Value

Iron Mountain Incorporated's stock is valued at $39.53 at 14:22 EST, below its 52-week high of $41.32 and way higher than its 52-week low of $21.54.

Iron Mountain Incorporated's Moving Average

Iron Mountain Incorporated's value is way above its 50-day moving average of $35.43 and way above its 200-day moving average of $30.33.

4. Builders FirstSource

105.7% sales growth and 31.71% return on equity

Builders FirstSource, Inc. manufactures and supplies building materials, manufactured components, and construction services to professional homebuilders, sub-contractors, remodelers, and consumers in the United States.

Builders FirstSource's sales growth this year is expected to be 73.1% and a negative 1.5% for next year.

Year-on-year quarterly revenue growth grew by 43.5%, now sitting on 8.56B for the twelve trailing months.

Builders FirstSource's sales growth for the next quarter is 105.7%. The company's growth estimates for the ongoing quarter and the next is 100% and 26.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 31.71%.

Volatility

Builders FirstSource's last day, last week, and last month's current volatility was 1.88%, 1.66%, and 1.60%, respectively.

Builders FirstSource's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.79% (day), 2.40% (last week), and 2.93% (last month), respectively.

Builders FirstSource's Stock Yearly Top and Bottom Value

Builders FirstSource's stock is valued at $49.97 at 14:22 EST, under its 52-week high of $50.83 and way above its 52-week low of $14.29.

Builders FirstSource's Moving Average

Builders FirstSource's value is higher than its 50-day moving average of $47.16 and way higher than its 200-day moving average of $40.51.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com